A detailed history of Capital Planning LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Planning LLC holds 6,084 shares of ABBV stock, worth $1.2 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
6,084
Previous 6,084 -0.0%
Holding current value
$1.2 Million
Previous $1.11 Million 5.78%
% of portfolio
0.33%
Previous 0.37%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $149,271 - $170,081
934 Added 18.14%
6,084 $1.11 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $383,035 - $439,316
-2,854 Reduced 35.66%
5,150 $691,000
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $83,948 - $106,725
-610 Reduced 7.08%
8,004 $1.23 Million
Q3 2021

Oct 19, 2021

SELL
$106.4 - $120.78 $4,468 - $5,072
-42 Reduced 0.49%
8,614 $929,000
Q2 2021

Jul 21, 2021

SELL
$105.21 - $117.21 $29,669 - $33,053
-282 Reduced 3.16%
8,656 $975,000
Q1 2021

Apr 22, 2021

SELL
$102.3 - $112.62 $43,784 - $48,201
-428 Reduced 4.57%
8,938 $967,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $753,869 - $1.02 Million
9,366 New
9,366 $1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Planning LLC Portfolio

Follow Capital Planning LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning LLC with notifications on news.